Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief medical officer, bringing back an industry veteran to lead its regulatory ...
The FDA granted fast track designation to ATSN-201 for the treatment of X-linked retinoschisis, according to a press release ...
The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director ...
The Trump administration’s moves to shrink the federal workforce put the FDA’s ability to regulate drugs and oversee the ...
3d
AllAfrica on MSNFDA Officer Escapes Traditional Arrest, Another Held HostageTwo Forestry Development Authority's agents, a Zone Warden, Selma Kolako, and a Ranger, Oliver Jelleh, are said to be in trouble for doing their work in the Grebo-Krahn National Partk, where they have ...
ImmunityBio (IBRX) announced U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty ...
Fortune on MSN13dOpinion
The DOGE-fueled firing of AI experts at the FDA endangers lives and worsens the hospital crisisThe FDA fired AI experts who conduct approvals for medical devices and might not get them back.
Patrizia Cavazzoni, formerly the top regulator of the drug division of the Food and Drug Administration, will join Pfizer as chief medical officer, a role in which she will lead the drug firm’s ...
Liquidmetal Technologies, Inc. ( OTCQB:LQMT) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Good afternoon. Welcome to the Liquidmetal Technologies Fiscal Year 2024 Conference Call. My ...
The National Cancer Institute (“NCI”), under its Cooperative Research and Development Agreement (“CRADA”) with PDS Biotech, will lead the Phase 1/2 clinical trial evaluating the combination of ...
These medications are not FDA-approved, meaning they do not undergo the rigorous testing for safety, effectiveness, and ...
Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results